Small interfering RNA (siRNA) targeting MDK could almost completely inhibit the MDK secretion in prostate cancer cells and enhance the cytotoxicity of paclitaxel-mediated chemotherapy [27]. The gene discussed is MDK; the disease is prostate carcinoma.